Lupin bags Health Canada nod for biosimilar Pegfilgrastim Ruchika Sharma25 Aug 2024 2:00 PM ISTArmlupeg is available in a form of pre-filled syringe of 6mg/0.6 ml.
CDSCO Panel grants Intas Package Insert update for Pegfilgrastim solution for injection 6mg/0.6mL vial and PFS Dr. Divya Colin5 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Center Drug Standard Control Organisation (CDSCO) has approved drug major Intas...
Aurobindo Pharma USA arm, Evive Biotech bags USFDA nod for Ryzneuta for Chemotherapy-Induced Neutropenia Ruchika Sharma22 Nov 2023 12:30 PM ISTRyzneuta is a novel long-acting Granulocyte colonystimulating factor (G-CSF), which can stimulate the proliferation, differentiation, and release of...
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Lupin, Axantia collaborate for Pegfilgrastim Ruchika Sharma2 Feb 2022 11:09 AM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that they have entered into a License, Supply and Technology Sharing agreement with...
Lupin, Biomm join hands for Pegfilgrastim distribution, marketing in Brazil Ruchika Sharma6 Dec 2021 4:03 PM ISTMumbai: Global pharma major, Lupin Limited has recently announced that the company has entered into an exclusive distribution and marketing agreement...
Lupin application for Pegfilgrastim biosimilar accepted by USFDA Ruchika Sharma3 Jun 2021 12:13 PM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that the USFDA has accepted the Biologics License Application (BLA) for its...
Sandoz Canada launches two new biosimilars Ziextenzo, Riximyo Ruchika Sharma23 Aug 2020 10:00 AM ISTBoucherville: Sandoz Canada Inc. has announced that it has reached a negotiated agreement with the Pan-Canadian...
Biocon Biologics gets EU GMP Certification for Bengaluru Manufacturing Facilities Ruchika Sharma21 May 2020 1:06 PM ISTBengaluru: Biocon Ltd has announced that its subsidiary Biocon Biologics India Ltd. has received the Certificate of GMP compliance from EMA for...
Biocon Biologics gets EU GMP Certification for Drug Substance Facilities, Bengaluru Ruchika Sharma13 May 2020 11:44 AM ISTBengaluru: Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. has received the Certificate of GMP compliance from EMA represented by the...
Biocon, Mylan Launch Fulphila, Biosimilar Pegfilgrastim in Canada Ruchika Sharma29 April 2020 2:35 PM ISTBengaluru: Biocon Ltd. and Mylan N.V. have announced the launch of Fulphila®, a biosimilar to Neulasta® (pegfilgrastim).Fulphila is approved by Health...
Biocon Biologics gets USFDA EIR for Two Manufacturing Facilities Ruchika Sharma17 April 2020 12:18 PM ISTBengaluru: Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR)...
